Exacerbations in COPD can have a major impact on patients, so early recognition and treatment are vital. Despite this, patients don’t always recognise them and underreporting of exacerbations is common – leading to under treatment and poorer outcomes. Our Open Up campaign encourages talking about exacerbations, which is why we have developed the COPD Exacerbation Recognition Tool (CERT), which we have licensed to GAAPP, a visual aid to help patients with COPD recognise the onset of an exacerbation and seek help promptly from their doctor. To find out more about CERT, visit https://gsk.to/4nX1Uzk
CERT makes a real difference by helping patients spot early warning signs—like worsening cough, shortness of breath, and increased sputum—so they can act quickly and avoid serious COPD flare-ups. Its simple checklist design leads to better reporting and earlier treatment, ultimately improving outcomes and keeping patients healthier. This kind of tool shows how practical innovations can empower patients and transform COPD management.
Evitar las exacerbaciones y en todo caso tratarlas lo antes posible, es la piedra angular del tratamiento de la EPOC. Anticipación es la palabra clave
Helpful post
This is new - age wellness! Awesome.
❤️❤️
A really important initiative — empowering patients to recognise exacerbations early can make a huge difference in managing COPD and improving quality of life👏
Senior Drug Safety Specialist | Literature Surveillance Expert | Regulatory Compliance | ICSR Management | Team Leadership | Award-Winning Performance | Immediate Joiner, No VISA Sponsorship required to work in the UK
1wThis is a fantastic campaign. Helping patients recognise exacerbations early is crucial, and CERT is a valuable step forward. Well done to everyone involved.